May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
February 2026
The peptide synthesis market size was valued at USD 678.12 million in 2025 and is expected to attain around USD 1,438.78 million by 2035 with a CAGR of 7.81%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
October 2025
The global peptide api market size is estimated to hit around USD 95.79 billion by 2034, increasing from USD 62.01 billion in 2025, with a CAGR of 4.95%.
September 2025
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
May 2026
The cell penetrating peptide market size was estimated at USD 2.48 billion in 2025 and is expected to hit around USD 9.95 billion by 2035, growing at a CAGR of 14.9%.
May 2026
The global injectable peptides drugs market size was evaluated at USD 48.60 billion in 2025 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
February 2026
The global marine peptide market size was evaluated at USD 308.25 million in 2025 and is predicted to hit around USD 547.88 million by 2035, growing at a CAGR of 5.92%.
January 2026
The global oral protein and peptide market size was evaluated at USD 9.43 billion in 2025 and is predicted to hit around USD 47.63 billion by 2035, growing at a CAGR of 17.58%.
January 2025
The global tuna peptides market size is estimated to hit around USD 1.64 billion by 2034 increasing from USD 1.02 billion in 2024, with a CAGR of 4.86%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com